Utilizing sinapic acid as an inhibitory antiviral agent against MERS-CoV PLpro
Concerns about the social and economic collapse, high mortality rates, and stress on the healthcare system are developing due to the coronavirus onslaught in the form of various species and their variants. In the recent past, infections brought on by coronaviruses severe acute respiratory syndrome c...
Main Authors: | Mudassar Shahid, Ahmed L. Alaofi, Mushtaq Ahmad Ansari, Sheikh Fayaz Ahmad, Saleh Alsuwayeh, Ehab Taha, Mohammad Raish |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016424000367 |
Similar Items
-
Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro
by: Ahmed L. Alaofi, et al.
Published: (2022-11-01) -
Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies
by: Mohammed Ali Dahhas, et al.
Published: (2023-02-01) -
Sinapic Acid Ameliorates Acetic Acid-Induced Ulcerative Colitis in Rats by Suppressing Inflammation, Oxidative Stress, and Apoptosis
by: Mudassar Shahid, et al.
Published: (2022-06-01) -
Sinapic acid alleviates 5-fluorouracil-induced nephrotoxicity in rats via Nrf2/HO-1 signalling
by: Mushtaq Ahmad Ansari, et al.
Published: (2023-07-01) -
Herb-drug interaction: Effect of sinapic acid on the pharmacokinetics of dasatinib in rats
by: Mudassar Shahid, et al.
Published: (2023-11-01)